SE
77
5
PSX
59
2
ADT
69
3
A
53
5
LEG
48
2
L
52
2
JPM
57
2
FE
37
2
DLTR
58
2
ORCL
63
4
OXY
41
3
VNO
46
-5
DVN
36
3
ADSK
53
-4
KMI
40
-2
IP
57
-3
ACN
42
2
DG
34
-6
NTAP
49
3
O
30
-3
SE
77
5
PSX
59
2
ADT
69
3
A
53
5
LEG
48
2
L
52
2
JPM
57
2
FE
37
2
DLTR
58
2
ORCL
63
4
OXY
41
3
VNO
46
-5
DVN
36
3
ADSK
53
-4
KMI
40
-2
IP
57
-3
ACN
42
2
DG
34
-6
NTAP
49
3
O
30
-3
Financhill
Back

Immuneering Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

IMRX
Immuneering

Last Price:
$4.19
Seasonality Move:
56.22%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Immuneering Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.23 Buy
20-day SMA: 3.61 Buy
50-day SMA: 2.44 Buy
200-day SMA: 2.01 Buy
8-day EMA: 4.1 Buy
20-day EMA: 3.63 Buy
50-day EMA: 2.82 Buy
200-day EMA: 2.25 Buy

Immuneering Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 67.2 Buy
Chaikin Money Flow: 612290 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.45 - 4.13) Buy
Bollinger Bands (100): (1.06 - 2.86) Buy

Immuneering Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Immuneering Stock

Is Immuneering Stock a Buy?

  • Immuneering share price is 4.30 while IMRX 8-day simple moving average is 4.23, which is a Buy signal.
  • The stock price of IMRX is 4.30 while Immuneering 20-day SMA is 3.61, which makes it a Buy.
  • Immuneering 50-day simple moving average is 2.44 while IMRX share price is 4.30, making it a Buy technically.
  • IMRX stock price is 4.30 and Immuneering 200-day simple moving average is 2.01, creating a Buy signal.

IMRX Technical Analysis vs Fundamental Analysis

Buy
57
Immuneering (IMRX) is a Buy

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Buy
    The current Immuneering [IMRX] share price is $4.30. The Score for IMRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.

Immuneering Stock Info

Market Cap:
154.7M
Price in USD:
4.30
Share Volume:
686.5K

Immuneering 52-Week Range

52-Week High:
4.60
52-Week Low:
1.00
Buy
57
Immuneering (IMRX) is a Buy

Immuneering Share Price Forecast

  • What is the Immuneering stock price today?
    The Immuneering stock price is 4.30 USD today.
  • Will IMRX stock go up or go down?
    Immuneering> share price is forecast to RISE/FALL based on technical indicators
  • Is Immuneering overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immuneering is not overvalued.

Is Immuneering Stock a Buy?

  • Immuneering share price is 4.30 while IMRX 8-day exponential moving average is 4.10, which is a Buy signal.
  • The stock price of IMRX is 4.30 while Immuneering 20-day EMA is 3.63, which makes it a Buy.
  • Immuneering 50-day exponential moving average is 2.82 while IMRX share price is 4.30, making it a Buy technically.
  • IMRX stock price is 4.30 and Immuneering 200-day simple moving average is 2.25, creating a Buy signal.

Fundamental Analysis of Immuneering

Is Immuneering a good investment?

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.07 per share, and an increase next year of $0.22 per share.

Technical Analysis of Immuneering

Should I short Immuneering stock?

* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.